Recent Vibrio cholerae O1 Epidemic Strains Are Unable To Replicate CTXΦ Prophage Genome.


Journal

mSphere
ISSN: 2379-5042
Titre abrégé: mSphere
Pays: United States
ID NLM: 101674533

Informations de publication

Date de publication:
30 06 2021
Historique:
pubmed: 10 6 2021
medline: 15 12 2021
entrez: 9 6 2021
Statut: ppublish

Résumé

Cholera, an acute diarrheal disease, is caused by pathogenic strains of Vibrio cholerae generated by the lysogenization of the filamentous cholera toxin phage CTXΦ. Although CTXΦ phage in the classical biotype are usually integrated solitarily or with a truncated copy, those in El Tor biotypes are generally found in tandem and/or with related genetic elements. Due to this structural difference in the CTXΦ prophage array, the prophage in the classical biotype strains does not yield extrachromosomal CTXΦ DNA and does not produce virions, whereas the El Tor biotype strains can replicate the CTXΦ genome and secrete infectious CTXΦ phage particles. However, information on the CTXΦ prophage array structure of pathogenic V. cholerae is limited. Therefore, we investigated the complete genomic sequences of five clinical V. cholerae isolates obtained in Kolkata (India) during 2007 to 2011. The analysis revealed that recent isolates possessed an altered CTXΦ prophage array of the prototype El Tor strain. These strains were defective in replicating the CTXΦ genome. All recent isolates possessed identical

Identifiants

pubmed: 34106768
doi: 10.1128/mSphere.00337-21
pmc: PMC8265649
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e0033721

Références

Cell. 1983 Nov;35(1):253-63
pubmed: 6627396
J Infect Dis. 1994 Aug;170(2):278-83
pubmed: 8035010
PLoS Negl Trop Dis. 2020 Apr 1;14(4):e0008128
pubmed: 32236098
J Clin Microbiol. 1986 Mar;23(3):652-4
pubmed: 3007571
Microbiol Immunol. 2018 Oct;62(10):635-650
pubmed: 30211956
Science. 1996 Dec 20;274(5295):2025-31
pubmed: 8953025
Nat Biotechnol. 2019 May;37(5):540-546
pubmed: 30936562
Science. 1996 Jun 28;272(5270):1910-4
pubmed: 8658163
J Bacteriol. 2007 Jul;189(13):4837-49
pubmed: 17468246
Microbiology (Reading). 2000 Oct;146 ( Pt 10):2605-2612
pubmed: 11021935
Mol Microbiol. 1997 Jun;24(5):917-26
pubmed: 9220000
Emerg Infect Dis. 2015 Nov;21(11):2100-2
pubmed: 26488385
J Bacteriol. 2000 Dec;182(24):6992-8
pubmed: 11092860
J Clin Microbiol. 2002 Sep;40(9):3296-9
pubmed: 12202569
BMC Microbiol. 2011 Jun 13;11:130
pubmed: 21668969
Genome Announc. 2018 Jun 21;6(25):
pubmed: 29930068
Arch Med Res. 1996 Autumn;27(3):275-83
pubmed: 8854382
Microbiol Mol Biol Rev. 1998 Dec;62(4):1301-14
pubmed: 9841673
Mol Microbiol. 2001 Jul;41(2):311-23
pubmed: 11489120
Appl Environ Microbiol. 2016 Apr 18;82(9):2833-2842
pubmed: 26944842
mSphere. 2020 Nov 18;5(6):
pubmed: 33208517
PLoS Comput Biol. 2017 Jun 8;13(6):e1005595
pubmed: 28594827
Proc Natl Acad Sci U S A. 2016 Nov 29;113(48):E7730-E7739
pubmed: 27849586
J Bacteriol. 2018 Jul 10;200(15):
pubmed: 29661863
J Clin Microbiol. 2012 Jul;50(7):2212-6
pubmed: 22518867
Microbiol Resour Announc. 2020 Jun 25;9(26):
pubmed: 32586863
PLoS One. 2014 Nov 21;9(11):e112973
pubmed: 25415339
Infect Immun. 1998 Aug;66(8):3752-7
pubmed: 9673258
Nature. 2019 Jan;565(7738):230-233
pubmed: 30602788
Nature. 2011 Aug 24;477(7365):462-5
pubmed: 21866102
Clin Microbiol Rev. 1995 Jan;8(1):48-86
pubmed: 7704895
Proc Natl Acad Sci U S A. 1999 Feb 2;96(3):1071-6
pubmed: 9927695
Genome Announc. 2018 Mar 1;6(9):
pubmed: 29496831
Infect Immun. 1987 Sep;55(9):2093-102
pubmed: 3623694
Microb Genom. 2017 Sep 14;3(10):e000132
pubmed: 29177090
Front Microbiol. 2019 Feb 05;10:111
pubmed: 30804907
Proc Natl Acad Sci U S A. 2017 Feb 28;114(9):2343-2348
pubmed: 28196886
Front Microbiol. 2019 Sep 06;10:2072
pubmed: 31555253
Emerg Infect Dis. 2011 Nov;17(11):2113-21
pubmed: 22099115
Proc Natl Acad Sci U S A. 2007 Mar 20;104(12):5151-6
pubmed: 17360342
Bioinformatics. 2015 Sep 1;31(17):2867-9
pubmed: 25910699
J Clin Microbiol. 1982 Jul;16(1):129-34
pubmed: 7107852
Proc Natl Acad Sci U S A. 1987 May;84(9):2833-7
pubmed: 2883655
PLoS One. 2014 Nov 19;9(11):e112963
pubmed: 25409509
PLoS One. 2013 Jun 11;8(6):e65342
pubmed: 23776471
J Bacteriol. 1999 Nov;181(21):6779-87
pubmed: 10542181
Emerg Infect Dis. 2014 Nov;20(11):1951-3
pubmed: 25340576
PLoS Negl Trop Dis. 2017 Feb 13;11(2):e0005386
pubmed: 28192431
J Clin Microbiol. 2011 Nov;49(11):3739-49
pubmed: 21880975
Infect Immun. 2020 Apr 20;88(5):
pubmed: 32094260
J Microbiol Biotechnol. 2014 Jun 28;24(6):725-31
pubmed: 24722374
Nucleic Acids Res. 2012 Apr;40(8):e55
pubmed: 22241772
mSphere. 2016 May 25;1(3):
pubmed: 27303743
Emerg Infect Dis. 2013 Jun;19(6):1015-7
pubmed: 23735934
Emerg Infect Dis. 2009 Jan;15(1):131-2
pubmed: 19116078
Trends Microbiol. 2010 Jan;18(1):46-54
pubmed: 19942436
N Engl J Med. 1980 Feb 7;302(6):305-9
pubmed: 7350497
Cell Host Microbe. 2018 Feb 14;23(2):274-281.e2
pubmed: 29398650
Emerg Infect Dis. 2015 Jul;21(7):1262-3
pubmed: 26079534
J Bacteriol. 2012 May;194(10):2772
pubmed: 22535947

Auteurs

Kaoru Ochi (K)

Department of Frontier Bioscience, Hosei University, Koganei, Tokyo, Japan.

Tamaki Mizuno (T)

Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama University, Okayama, Japan.

Prosenjit Samanta (P)

Division of Bacteriology, National Institute of Cholera and Enteric Diseases, Kolkata, India.

Asish K Mukhopadhyay (AK)

Division of Bacteriology, National Institute of Cholera and Enteric Diseases, Kolkata, India.

Shin-Ichi Miyoshi (SI)

Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama University, Okayama, Japan.

Daisuke Imamura (D)

Department of Frontier Bioscience, Hosei University, Koganei, Tokyo, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH